Abstract
The circadian changes in blood and urine minerals and parathyroid function assessed by nephrogenous cyclic AMP (NcAMP) and a highly sensitive midregion specific parathyroid hormone (PTH) radioimmunoassay (RIA) were investigated for 26 hours in ten healthy 23 to 53-year-old males (group 1) with normal food intakes. Also, we studied another six male and four female adults between 600 and 1200 h as fasting controls (group 2). The blood calcium (Ca) levels were the highest at 630 h in both groups and decreased thereafter, and the diurnal variation of NcAMP reflected that of serum Ca, showing a low value in the morning. There were significant negative correlations between total Ca and NcAMP in both groups 1 and 2 (r=−0.323, n=130, p<0.01; r=−0.525, n=60, p<0.01), suggesting that the blood Ca level is the major determinant of parathyroid function and that NcAMP is a good indicator of blood Ca related PTH secretion in healthy individuals. This last relationship was not seen between Ca and midregion PTH levels presumably owing to slow clearance of PTH fragments from the circulation. However, midregion PTH perhaps because of its long half life, not NcAMP, shows a significant inverse relation to urinary Ca excretion (mg/dIGF) in the diurnal variation in healthy individuals (r=−0.560, n=130, p<0.01). The circadian pattern (s) of serum phosphate (P) consisted of a minium level at 900–1100 h followed by two peaks, at 1400–1600 h and 2200–2400 h. Thus, this study conducted in healthy individuals under physiologic condition clearly demonstrated that the NcAMP level reflects blood Ca related PTH secretion and that urinary Ca excretion seems to be determined by the sum of PTH secretion.
Similar content being viewed by others
References
Markowitz ME, Rosen JF, Laximinarayan S, Mizrchi M. Circadian rhythms of blood minerals during adolescence. Pediatric Res 18: 456–462, 1984.
Markowitz ME. Circadian rhythms of blood minerals in humans. Science 213: 672–674, 1981.
Brauman J, Delvigne CH, Brauman H. Measure of blood ionized Ca versus total calcium in normal man, renal insufficiency and hypercalcemia of various origins. Scand J clin Lab Invest 43 (Suppl 165): 75, 1983.
LoCascio V, Cominacini L, Adami S, Galvanini G, Davoli A, Scuro LA. Relationship of total and ionized serum calcium circadian variations in normal and hyperparathyroid subjects Horm metabol Res 14: 443, 1983.
Gleed JH, Hendy GN, Nussbaum SR, Rosenblatt M, O'Riordan LH. Development and application of a mid-region specific assay for human parathyroid hormone. Clin Endocr 24: 365–373, 1986.
Goltzman D, Gomolin H, DeLean A, Wexler M, Meakins JL. Discordant disappearance of bioactive and immunoreactive parathyroid hormone after parathyroidectomy. J Clin Endocrinol Metab 58: 70–75, 1984.
Segre GV. Amino-terminal radioimmunoassay for human parathyroid hormone. In Endocrine control of bone and calcium metabolism (Cohn DV, Potts JTJr, Fujita T eds) Elsevier Scientific Publishers BV 1984; pp17–19
Robinson MF, Body JJ, Offord KP, Heath H III. Variation of plasma immunoreactive parathyroid hormone and calcitonin in normal and hyperparathyroid man during daylight hours. J Clin Endocrinol Metab 55: 538, 1982.
Mallette LE. Radioimmunoassay secific for the midregion (44–68) of parathyroid hormone. In Endocrine control of bone and calcium metabolism (cohn DV, Potts JTJr, Fujita T eds) Elsevier Scientific Publishers BV 1984; pp21–23
Fukase M, Fujita T, Matumoto T, Ogata E, Iijima T, Takezawa J, Saito K, Ishige H, Fujimoto M.: Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic states. Folia Endocrinol 65: 807–827, 1989.
Broadus AE, Dominiquez M, Bartter FC: Pathophysiological studies in idiopathic calciuria: Use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroup. J Clin Endocrinol Metab 47: 751–760, 1978.
Thode J, Nistrup S, Siggaard-Anderson O. Serum ionized calcium, nephrogenous and total cyclic AMP and urinary phosphate in normal subjects. Scand J Clin Lab Invest 44: 111–118, 1984.
Nussbaum SR, Zahradnik RJ, Lavigne JR, Potts Jr JT, Segre GV. A highly sensitive two-site immunoradiometric assay of parathyrin (PTH) and clinical utility in evaluating patients with hypercalcemia. Clin chem. 33: 1364–1367, 1987.
Kitamura N, Shigeno C, Shiomi K, Lee K, Ohta S, Sone T, Katsushima S, Tadamura E, Kousaka T, Yamamoto I, Dokoh S and Konishi J.: Episodic fluctuation in serum intact parathyroid hormone concentration in men. J Clin Endocrinol Metab 70: 252–263, 1990.
Sutton R A. Disorders of renal calcium excretion. Kidney International 23: 665–673, 1983.
Yasuda T. Hypoparathyroidism. Pharma Media 3: 57–62, 1985. (in Japanese).
Yamamoto M, Takuwa Y, Masuko S, Ogata E. Effects of endogenous and exogenous parathyroid hormone on renal tubular reabsorption of calcium in pseudohypopara thyroidism. J Clin Endocrinol Metab 66:618–625, 1988.
Demay M, Mitchell J, Goltzman D. Comparison of renal and osseous binding of parathyroid hormone and hormone fragments. Am J Physiol. 249: E437, 1985.
Yamaguchi, Fukase M, and Fujita T. Control of parathyroid hormone-degrading activity in the opossum kidney cell: possible involvement of protein kinase C. Biochem Biophys Res Commun 157: 908–913, 1988.
Author information
Authors and Affiliations
About this article
Cite this article
Yasuda, T., Iijima, T., Takezawa, J. et al. Demonstration of blood calcium-related parathyroid function in the diurnal variation of blood and urine calcium and phosphorus in healthy individuals. J Bone Miner Metab 9, 78–85 (1991). https://doi.org/10.1007/BF02377989
Issue Date:
DOI: https://doi.org/10.1007/BF02377989